Locations:

Tag: lenalidomide

January 24, 2025/Cancer/News & Insight

Researchers Seek Actionable Ways to Reduce Time to Treatment of Multiple Myeloma

Study examines modifiable determinants of health disparities

May 8, 2020/Cancer/Research

Study Identifies Safety Concern about Bortezomib as Post-Transplant GVHD Prophylaxis in High-Risk Multiple Myeloma

Surprising outcome differs from previous results

December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

August 22, 2019/Geriatrics

Lenalidomide for Early Alzheimer’s: Taking on Multiple Neuropathologies at Once

New clinical trials size up an immunomodulator’s pleiotropic effects

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next